XC8

DRUG4 trials

Sponsors

PHARMENTERPRISES LLC, Valenta Pharm JSC

Conditions

Acute Respiratory InfectionAsthmaHealthyInfluenzaRespiratory Viral Infection

Phase 1

XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers

CompletedNCT03441815

PHARMENTERPRISES LLCAsthma

Start: 2015-02-14End: 2015-07-07Updated: 2018-02-22

Study of the Effect of Food Intake on the Bioavailability of XC8 10 mg Film-coated Tablets

CompletedNCT05294250

Valenta Pharm JSCHealthy

Start: 2022-02-01End: 2022-02-26Updated: 2023-07-27

Phase 3

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

RecruitingNCT06379542

Valenta Pharm JSCAcute Respiratory Infection

Start: 2023-12-04End: 2025-12-31Target: 252Updated: 2024-04-23

Unknown Phase

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

CompletedNCT05558462

Valenta Pharm JSCInfluenza, Respiratory Viral Infection

Start: 2022-08-22End: 2022-12-07Updated: 2023-10-10